1. Sex‐based differences in outcomes with bivalirudin or unfractionated heparin for transcatheter aortic valve replacement: Results from the BRAVO‐3 randomized trial. Issue 1 (16th August 2016) Authors: Asgar, A.; Chandrasekhar, J.; Mikhail, G.; Webb, J.; Lefèvre, T.; Tamburino, C.; Hildick‐Smith, D.; Hambrecht, R.; Van Belle, E.; Widder, J.; Dumonteil, N.; Hink, U; Jeger, R.; Linke, A.; Deliargyris, E.; Gao, P.; Mehran, R.; Hengstenberg, C.; Anthopoulos, P.; Dangas, G. Journal: Catheterization and cardiovascular interventions Issue: Volume 89:Issue 1(2017) Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗